MetaVia Inc. Soared
Wed, May 20, 2026 at 07:41 PM
MetaVia Inc. (MTVA:NASDAQ) shot up at $2.89, a gain of 53.7%. On Wed, May 20, 2026, MTVA:NASDAQ touched a New 2-Week High of $2.89. The stock got featured on our News Catalysts scanner on Mon, May 18, 2026 at 10:09 AM in the 'MISCELLANEOUS' category. From Wed, May 06, 2026, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Dec 08, 2025 at $13.42 with a volume of 2M+.
About MetaVia Inc. (MTVA:NASDAQ)
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative...
Top 10 Gainers:
- HCW Biologics Inc. (HCWB:NASDAQ), 129.25%
- Silexion Therapeutics Corp (SLXN:NASDAQ), 96.95%
- GCL Global Holdings Ltd (GCL:NASDAQ), 72.46%
- BiomX Inc. (PHGE:NYSEMKT), 59.6%
- MetaVia Inc. (MTVA:NASDAQ), 53.72%
- Micware Co. Ltd. (MWC:NASDAQ), 51.48%
- TDH Holdings, Inc. (PETZ:NASDAQ), 41.98%
- MicroAlgo Inc. (MLGO:NASDAQ), 39.95%
- Immunovant, Inc. (IMVT:NASDAQ), 35.26%
- Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ), 34.67%